Your fact-checks will appear here
The study and treatment of diabetes, including the GLP-1 pathway
Randomized trials and multiple meta-analyses report that is repeatedly associated with modest, statistically significant reductions in fasting plasma glucose, while effects on hemoglobin A1c (HbA1c) a...
GLP-1 receptor agonists are effective medicines that have transformed diabetes and obesity treatment, delivering substantial weight loss and cardiovascular and metabolic benefits in trials and real-wo...
Collagen peptides do not appear to cause harmful, isolated “insulin spikes” in the sense of provoking pathological hyperinsulinemia; instead, preclinical and limited clinical data show collagen peptid...
Clinical and mechanistic studies show plausible pathways by which berberine and certain probiotics could raise GLP‑1 secretion, but controlled human trials demonstrating a reproducible, physiologicall...